Clinical trial
Safety and Effectiveness of Single-dose Subconjunctival Triamcinolone Compared to Topical Prednisolone Eye Drops in Manual Small Incision Cataract Surgery
NCT05248139 is registered in ClinicalTrials.gov with Visualiza as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Safety and Effectiveness of Single-dose Subconjunctival Triamcinolone Compared to Topical Prednisolone Eye Drops in Manual Small Incision Cataract Surgery
- Lead sponsor
- Visualiza
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- October 31, 2022
- Completion date
- February 28, 2023
- Enrollment
- 100 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
cataract, ocular hypertension, ocular inflammation, post-op complication